William Robert Moore - Publications

Affiliations: 
1972 Massachusetts Institute of Technology, Cambridge, MA, United States 
 1972-1997 West Virginia University, Morgantown, WV, United States 
Area:
physical organic chemistry
Website:
http://eberly.wvu.edu/eberly_news/2010/1/7/c--eugene-bennett-department-of-chemistry-holds-memorial-service-for-moore

13/253 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1971 Moore WR, King BJ. Stereospecific intramolecular insertion of the cyclopropylidenes produced in the reaction of cis- and trans-3-tert-butyl-7,7-dibromobicyclo[4.1.0]heptane with methyllithium Journal of Organic Chemistry. 36: 1877-1882. DOI: 10.1021/Jo00813A007  0.329
1971 Moore WR, Bell LN, Daumit GP. Synthesis of cis- and trans-tricyclo[6.4.0.02,7]dodeca-2,12-diene by the intramolecular coupling of disilver reagents Journal of Organic Chemistry. 36: 1694-1695. DOI: 10.1021/Jo00811A028  0.319
1971 Moore WR, Bell LN, Daumit GP. Red. Von Cis- Und Trans-Tricyclo(6,4,0,0(2,7))Dodecadien-(2,12) Mit Lithiu Spaltung Der Zentralbindung Eines 1,3-Diens Cheminform. 2. DOI: 10.1002/Chin.197103206  0.311
1970 Cope AC, Moore WR, Bach RD, Winkler HJS. Molecular asymmetry. IX. The partial resolution and asymmetric synthesis of 1,2-cyclononadiene Journal of the American Chemical Society. 92: 1243-1247. DOI: 10.1021/Ja00708A023  0.462
1970 Moore WR, Moser WR. Rk. Von 6,6-Dibrom-Bicyclo(3,1,0)Hexan Mit Methyllithium, Beweis Der Bldg. Von Cyclohexadien-(1,2) Und Dicyclohexenylen-(2,2′) Cheminform. 1. DOI: 10.1002/Chin.197047120  0.3
1970 Cope AC, Moore WR, Bach RD, Winkler HJS. Molekuelasymmetrie 9. Mitt. Teilspaltung Und Asymmetrische Synth. Von Cyclononadien-(1,2) Cheminform. 1. DOI: 10.1002/Chin.197022108  0.452
1967 Moore WR, Ozretich TM. Cyclic cumulenes. The synthesis and some reactions of 1,2,3-cyclodecatriene Tetrahedron Letters. 8: 3205-3207. DOI: 10.1016/S0040-4039(01)89900-7  0.302
1961 Cope AC, LeBel NA, Moore PT, Moore WR. Mechanism of the Hofmann elimination reaction: Evidence that an ylide intermediate is not involved in simple compounds Journal of the American Chemical Society. 83: 3861-3865. DOI: 10.1021/Ja01479A029  0.436
1960 Cope AC, Moore PT, Moore WR. Equilibration of cis- and trans-cycloalkenes Journal of the American Chemical Society. 82: 1744-1749. DOI: 10.1021/Ja01492A051  0.427
1959 Cope AC, Moore PT, Moore WR. RELATIVE STABILITIES OF cis- AND trans-CYCLONONENE, CYCLODECENE, CYCLOUNDECENE AND CYCLODODECENE Journal of the American Chemical Society. 81: 3153-3153. DOI: 10.1021/Ja01521A067  0.424
1959 Moore WR, Marcus E, Fenton SE, Arnold RT. Possible effect of hyperconjugation on solvolysis rates of benzhydryl chlorides and spectra of related compounds Tetrahedron. 5: 179-185.  0.461
1958 Cope AC, Moore PT, Moore WR. Cyclic polyolefins. XLIV. The structure of cycloöctatetraene oxide Journal of the American Chemical Society. 80: 5505-5507. DOI: 10.1021/Ja01553A048  0.372
1955 Cope AC, Moore WR. Cyclic Polyolefins. Xxxviii. Position Isomers Of Disubstituted Cycloöctatetraenes Journal of the American Chemical Society. 77: 4939-4940. DOI: 10.1021/Ja01623A084  0.419
Low-probability matches (unlikely to be authored by this person)
1970 Moore WR, Bell LN, Daumit GP. Reduction of cis- and trans-tricyclo[6.4.0.02,7]dodeca-2,12-diene with lithium. Cleavage of the central bond of a 1,3-diene Journal of the American Chemical Society. 92: 6680-6682. DOI: 10.1021/Ja00725A072  0.294
1970 Moore WR, Taylor KG, Müller P, Hall SS, Gaibel ZLF. The synthesis and some reactions of 1,2,2-trimethylbicyclobutane Tetrahedron Letters. 11: 2365-2368. DOI: 10.1016/S0040-4039(01)98230-9  0.293
1997 Hirschmann R, Yager KM, Taylor CM, Witherington J, Sprengeler PA, Phillips BW, Moore W, Smith AB. Phosphonate Diester and Phosphonamide Synthesis. Reaction Coordinate Analysis by 31P NMR Spectroscopy: Identification of Pyrophosphonate Anhydrides and Highly Reactive Phosphonylammonium Salts1 Journal of the American Chemical Society. 119: 8177-8190. DOI: 10.1021/Ja962465O  0.285
1971 Moore WR, Costin CR. Synthesis of 2,2,3,2',2',3'-hexamethylbis(1-bicyclo[1.1.0]butyl). Conjugation in a formally saturated system Journal of the American Chemical Society. 93: 4910-4912. DOI: 10.1021/Ja00748A045  0.285
1970 Moore WR, Hill JB. Competitive bicyclobutane and allene formation from phenyl-substituted gem-dibromocyclopropanes Tetrahedron Letters. 11: 4553-4556. DOI: 10.1016/S0040-4039(00)89415-0  0.281
1971 Moore WR, Costin CR. Synth. Von 2,2,3,2′,2′,3′-Hexamethyl-Bis-(1-Bicyclo(1,1,0)Butyl), Konjugation In Einem Formal Gesaettigtem Syst. Cheminform. 2. DOI: 10.1002/Chin.197149240  0.269
1970 Moore WR, Taylor KG, Mueller P, Hall SS, Gaibel ZLF. Synth. Und Einige Rk. Von 1,2,2-Trimethylbicyclobutan Cheminform. 1. DOI: 10.1002/Chin.197038240  0.261
1971 Moore WR, Anderson HW, Clark SD, Ozretich TM. Absolute Konfig. Von (+)-Cyclononadien-(1,2) Cheminform. 2. DOI: 10.1002/Chin.197148087  0.26
1995 Hirschmann R, Yager KM, Taylor CM, Moore W, Sprengeler PA, Witherington J, Phillips BW, Smith ABI. Phosphonyltriethylammonium Salts : Novel Reactive Species For The Synthesis Of Phosphonate Esters And Phosphononamides Journal of the American Chemical Society. 117: 6370-6371. DOI: 10.1021/Ja00128A032  0.255
1971 Moore WR, Anderson HW, Clark SD, Ozretich TM. Absolute configuration of (+)-1,2-cyclononadiene Journal of the American Chemical Society. 93: 4932-4934. DOI: 10.1021/Ja00748A059  0.248
1970 Moore WR, Moser WR. Reaction of 6,6-dibromobicyclo[3.1.0]hexane with methyllithium. Evidence for the generation of 1,2-cyclohexadiene and 2,2'-dicyclohexenylene Journal of the American Chemical Society. 92: 5469-5474. DOI: 10.1021/Ja00721A028  0.246
1969 Moore WR, Hall SS, Largman C. The reduction of bicyclobutanes to cyclobutanes by lithium in primary amines Tetrahedron Letters. 10: 4353-4356. DOI: 10.1016/S0040-4039(01)88694-9  0.243
1970 Moore WR, Hall SS, Largman C. Red. Von Bicyclobutanen Zu Cyclobutanen Durch Lithium In Prim. Aminen Cheminform. 1. DOI: 10.1002/Chin.197004054  0.237
1973 Moore WR, Anderson HW, Clark SD. Rueckgewinnung Von R-Allenen Bei Der Partiellen Hydroborierung Racemischer Allene Mit (+)-Tetra-(Pinanyl-(3))-Diboran, Modell Der Hydroborierung Von Olefinen Und Allenen Cheminform. 4. DOI: 10.1002/Chin.197316177  0.225
1973 Moore WR, Anderson HW, Clark SD. Recovery of R allenes from the partial hydroboration of racemic allenes with (+)-tetra-3-pinanyldiborane. Model for hydroboration of olefins and allenes Journal of the American Chemical Society. 95: 835-844. DOI: 10.1021/Ja00784A034  0.221
1972 Moore WR, Mogolesko PD, Traficante DD. Dimerisation Von Cyclohexadien-(1,2), Ein Modell Fuer Eine Nichtkonzertierte Allen-Dimerisation, Bestimmung Eines Sekundaeren Kinetischen Deuterium-Isotopeneffektes Mittels D-Nmr Cheminform. 3. DOI: 10.1002/Chin.197238134  0.219
1972 Moore WR, Mogolesko PD, Traficante DD. Dimerization of 1,2-cyclohexadiene, a model for nonconcerted allene dimerization. Determination of a secondary deuterium kinetic isotope effect by deuterium nuclear magnetic resonance Journal of the American Chemical Society. 94: 4753-4754. DOI: 10.1021/Ja00768A066  0.207
1970 Moore WR, Hill JB. Selective insertion in the formation of bicyclobutanes from tetraalkylsubstituted gem-dibromocyclopropanes Tetrahedron Letters. 11: 4343-4346. DOI: 10.1016/S0040-4039(00)89481-2  0.203
1992 Moore WR, Schatzman GL, Jarvi ET, Gross RS, McCarthy JR. Terminal difluoro olefin analogs of squalene are time-dependent inhibitors of squalene epoxidase Journal of the American Chemical Society. 114: 360-361. DOI: 10.1021/Ja00027A056  0.202
1972 Moore WR, Bach RD. Bldg. Von Optisch Aktivem Cyclononadien-(1,2) Aus Zwei Verschiedenen Cyclopropyliden-Vorstufen Cheminform. 3. DOI: 10.1002/Chin.197229216  0.188
1969 Moore WR, Bach RD, Ozretich TM. Dimerization of racemic and optically active 1,2-cyclononadiene Journal of the American Chemical Society. 91: 5918-5919. DOI: 10.1021/Ja01049A059  0.181
1994 Krikorian SE, Moore WR. Triiodoethylene: A Product of the Thermal Decomposition of Diiodoacetylene Journal of Organic Chemistry. 59: 3742-3743. DOI: 10.1021/Jo00092A047  0.181
1962 Moore WR, Bertelson RC. The Synthesis and Some Reactions of 1,2-Cyclononadiene and 1,2-Cyclodecadiene The Journal of Organic Chemistry. 27: 4182-4186. DOI: 10.1021/JO01059A014  0.17
1963 Moore WR, Ward HR. The Equilibration of Cyclic Allenes and Acetylenes Journal of the American Chemical Society. 85: 86-89. DOI: 10.1021/JA00884A018  0.138
1963 Moore WR, Moser WR, LaPrade JE. Reactions of the Dibromocarbene Adducts of Bicyclo[2.2.1]heptene and Bicyclo[2.2.1]heptadiene The Journal of Organic Chemistry. 28: 2200-2205. DOI: 10.1021/JO01044A012  0.135
1962 Moore WR, Ward HR. The Formation of Allenes from gem-Dihalocyclopropanes by Reaction with Alkyllithium Reagents1,2 The Journal of Organic Chemistry. 27: 4179-4181. DOI: 10.1021/JO01059A013  0.128
1994 Marquart AL, Schatzman GL, Peet NP, Moore WR, Huber EW, Gallion SL, Angelastro MR. Inhibition of oxidosqualene cyclase by substituted quinolizidines Bioorganic & Medicinal Chemistry Letters. 4: 1317-1318. DOI: 10.1016/S0960-894X(01)80352-8  0.121
2011 Shetty RS, Lee Y, Liu B, Husain A, Joseph RW, Lu Y, Nelson D, Mihelcic J, Chao W, Moffett KK, Schumacher A, Flubacher D, Stojanovic A, Bukhtiyarova M, Williams K, ... ... Moore WR, et al. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent. Journal of Medicinal Chemistry. 54: 179-200. PMID 21126027 DOI: 10.1021/Jm100659V  0.119
2011 Moore W, Ripton-Snyder J, Wu G, Hendler C. Sensitivity and specificity of a CAD solution for lung nodule detection on chest radiograph with CTA correlation. Journal of Digital Imaging. 24: 405-10. PMID 20354756 DOI: 10.1007/s10278-010-9284-7  0.118
1987 Moore WR, Meister A. Enzymatic synthesis of novel glutathione analogs. Analytical Biochemistry. 161: 487-93. PMID 3555155 DOI: 10.1016/0003-2697(87)90478-7  0.114
1960 Moore W, Ward H. Communications- Reactions of gem-Dibromocyclopropanes with Alkyllithium Reagents. Formation of Allenes, Spiropentanes, and a Derivative of Bicyclopropylidene The Journal of Organic Chemistry. 25: 2073-2073. DOI: 10.1021/JO01081A054  0.112
1962 Moore WR. An Interpretation of The Formation of trans-Cycloalkenes in The Partial Hydrogenation of Certain Cyclic Dienes Journal of the American Chemical Society. 84: 3788-3789. DOI: 10.1021/JA00878A053  0.108
1970 Moore WR, Moser WR. Reaction of 6,6-dibromobicyclo[3.1.0]hexane with methyllithium. Efficient trapping of 1,2-cyclohexadiene by styrene The Journal of Organic Chemistry. 35: 908-912. DOI: 10.1021/JO00829A008  0.104
1971 Moore WR, King BJ. Derivatives of bicyclobutane and bicyclo[2.1.0]pentane. Establishment of the structures of 3- and 4-tert-butyltricyclo[4.1.0.02,7yheptane and 5- and exo-4-tert-butyltricyclo[3.2.0.02,7]heptane The Journal of Organic Chemistry. 36: 1882-1886. DOI: 10.1021/JO00813A008  0.103
2003 Weintraub PM, Holland AK, Gates CA, Moore WR, Resvick RJ, Bey P, Peet NP. Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase. Bioorganic & Medicinal Chemistry. 11: 427-31. PMID 12517438 DOI: 10.1016/S0968-0896(02)00434-0  0.093
1963 Moore WR, Krikorian SE, LaPrade JE. The Formation of Hexachlorocyclopropane by the Addition of Dichlorocarbene to Tetrachloroethylene The Journal of Organic Chemistry. 28: 1404-1405. DOI: 10.1021/JO01040A516  0.086
2017 Henke W, Lionetti D, Moore W, Hopkins J, Day V, Blakemore J. Ligand Substituents Govern the Efficiency and Mechanistic Path of Hydrogen Production with [Cp*Rh] Catalysts. Chemsuschem. PMID 29024563 DOI: 10.1002/Cssc.201701416  0.085
1998 Katz BA, Clark JM, Finer-Moore JS, Jenkins TE, Johnson CR, Ross MJ, Luong C, Moore WR, Stroud RM. Design of potent selective zinc-mediated serine protease inhibitors. Nature. 391: 608-12. PMID 9468142 DOI: 10.1038/35422  0.07
1971 Crabbé P, Velarde E, Anderson HW, Clark SD, Moore WR, Drake AF, Mason SF. Optical activity and absolute configuration of chiral allenes Journal of the Chemical Society D: Chemical Communications. 1261-1264. DOI: 10.1039/C29710001261  0.067
2013 Maity SN, Wu G, Lu J, Eisner JR, Rafferty SW, Schotzinger RJ, Moore WR, Logothetis CJ, Araujo JC, Efstathiou E. Abstract 4772: Efficacy of VT-464, a novel selective inhibitor of cytochrome P450 17,20-lyase, in castrate-resistant prostate cancer models. Cancer Research. 73: 4772-4772. DOI: 10.1158/1538-7445.Am2013-4772  0.066
2015 Lovering F, Aevazelis C, Chang J, Dehnhardt C, Fitz L, Han S, Janz K, Lee J, Kaila N, McDonald J, Moore W, Moretto A, Papaioannou N, Richard D, Ryan MS, et al. Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP). Chemmedchem. PMID 26381330 DOI: 10.1002/cmdc.201500333  0.066
1999 Cregar L, Elrod KC, Putnam D, Moore WR. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. Archives of Biochemistry and Biophysics. 366: 125-30. PMID 10334872 DOI: 10.1006/abbi.1999.1220  0.063
2012 Eisner JR, Abbott DH, Bird IM, Rafferty SW, Moore WR, Schotzinger RJ. VT-464: A novel, selective inhibitor of P450c17(CYP17)-17,20 lyase for castration-refractory prostate cancer (CRPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 198. PMID 28143192 DOI: 10.1200/jco.2012.30.5_suppl.198  0.063
2012 Eisner JR, Abbott DH, Bird IM, Rafferty SW, Moore WR, Schotzinger RJ. VT-464: A novel, selective inhibitor of P450c17(CYP17)-17,20 lyase for castration-refractory prostate cancer (CRPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 198. PMID 27968133 DOI: 10.1200/jco.2012.30.5_suppl.198  0.063
2014 Moore WR, Maity SN, Eisner JR, Garvey EP, Hoekstra WJ, Titus MA, Logothetis C, Araujo JC, Efstathiou E, Schotzinger RJ. The enzymology of the selective CYP17 lyase inhibitor, VT-464, and its effects in castration-resistant prostate cancer (CRPC) models. Journal of Clinical Oncology. 32: 158-158. DOI: 10.1200/Jco.2014.32.4_Suppl.158  0.062
1992 Wannamaker MW, Waid PP, Van Sickle WA, McCarthy JR, Wilson PK, Schatzman GL, Moore WR. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase. Journal of Medicinal Chemistry. 35: 3581-3. PMID 1404239  0.058
1998 Rice KD, Tanaka RD, Katz BA, Numerof RP, Moore WR. Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Current Pharmaceutical Design. 4: 381-96. PMID 10197050  0.057
2000 Janc JW, Clark JM, Warne RL, Elrod KC, Katz BA, Moore WR. A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II). Biochemistry. 39: 4792-800. PMID 10769136 DOI: 10.1021/BI992182J  0.056
2015 Toren PJ, Kim S, Pham S, Mangalji A, Adomat H, Guns ES, Zoubeidi A, Moore W, Gleave ME. Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer. Molecular Cancer Therapeutics. 14: 59-69. PMID 25351916 DOI: 10.1158/1535-7163.Mct-14-0521  0.055
2017 Norris JD, Ellison SJ, Baker JG, Stagg DB, Wardell SE, Park S, Alley HM, Baldi RM, Yllanes A, Andreano KJ, Stice JP, Lawrence SA, Eisner JR, Price DK, Moore WR, et al. Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer. The Journal of Clinical Investigation. PMID 28463227 DOI: 10.1172/Jci87328  0.054
2024 Chapple B, Woodfin S, Moore W. The Perfect Cup? Coffee-Derived Polyphenols and Their Roles in Mitigating Factors Affecting Type 2 Diabetes Pathogenesis. Molecules (Basel, Switzerland). 29. PMID 38398503 DOI: 10.3390/molecules29040751  0.054
2014 Warrilow AG, Hull CM, Parker JE, Garvey EP, Hoekstra WJ, Moore WR, Schotzinger RJ, Kelly DE, Kelly SL. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrobial Agents and Chemotherapy. 58: 7121-7. PMID 25224009 DOI: 10.1128/AAC.03707-14  0.054
2017 Wardell SE, Yllanes AP, Norris JD, Stice JP, White H, Fleming RA, Strum JC, Moore WR, McDonnell DP. Abstract 1588: Effects of the selective CYP17-lyase and androgen receptor (AR) inhibitor, seviteronel, and the cyclin-dependent kinase (CDK) 4/6 inhibitor, G1T38, on tumor growth in an AR-V7+ castration-resistant prostate cancer (CRPC) xenograft model Cancer Research. 77: 1588-1588. DOI: 10.1158/1538-7445.Am2017-1588  0.053
1962 Moore WR, Arzoumanian H. The Formation of 3,4-Benzocoumarin by the Lead Tetraacetate Oxidation of Diphenic Acid The Journal of Organic Chemistry. 27: 4667-4668. DOI: 10.1021/JO01059A520  0.053
2016 Ellison S, Norris J, Wardell S, Eisner J, Hoekstra W, Stagg D, Alley H, Moore W, McDonnell D. Abstract P3-14-04: Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER+ tumor models in vitro and in vivo Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-14-04  0.052
2014 Hoekstra WJ, Garvey EP, Moore WR, Rafferty SW, Yates CM, Schotzinger RJ. Design and optimization of highly-selective fungal CYP51 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 3455-8. PMID 24948565 DOI: 10.1016/j.bmcl.2014.05.068  0.05
1989 Moore WR, Anderson ME, Meister A, Murata K, Kimura A. Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli: a possible model for mammalian cell protection. Proceedings of the National Academy of Sciences of the United States of America. 86: 1461-4. PMID 2564202 DOI: 10.1073/Pnas.86.5.1461  0.048
2014 Toren P, Pham S, Kim S, Adomat H, Zoubeidi A, Moore WR, Gleave ME. Anticancer activity of the selective CYP17A1 inhibitor, VT-464, in preclinical models of castrate-resistant prostate cancer. Journal of Clinical Oncology. 32: 104-104. DOI: 10.1200/Jco.2014.32.4_Suppl.104  0.048
2020 Oshima N, Ishida R, Kishimoto S, Beebe K, Brender JR, Yamamoto K, Urban D, Rai G, Johnson MS, Benavides G, Squadrito GL, Crooks D, Jackson J, Joshi A, Mott BT, ... ... Moore W, et al. Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy. Cell Reports. 30: 1798-1810.e4. PMID 32049011 DOI: 10.1016/J.Celrep.2020.01.039  0.047
2013 Kanakia S, Toussaint JD, Chowdhury SM, Lalwani G, Tembulkar T, Button T, Shroyer KR, Moore W, Sitharaman B. Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agent. International Journal of Nanomedicine. 8: 2821-33. PMID 23946653 DOI: 10.2147/Ijn.S47062  0.047
2018 Walker SI, Bains W, Cronin L, DasSarma S, Danielache S, Domagal-Goldman S, Kacar B, Kiang NY, Lenardic A, Reinhard CT, Moore W, Schwieterman EW, Shkolnik EL, Smith HB. Exoplanet Biosignatures: Future Directions. Astrobiology. 18: 779-824. PMID 29938538 DOI: 10.1089/Ast.2017.1738  0.046
2015 Han F, Wang H, Zhang G, Han H, Song B, Li L, Moore W, Lu H, Zhao H, Liang Z. Texture feature analysis for computer-aided diagnosis on pulmonary nodules. Journal of Digital Imaging. 28: 99-115. PMID 25117512 DOI: 10.1007/s10278-014-9718-8  0.046
2014 Rafferty SW, Eisner JR, Moore WR, Schotzinger RJ, Hoekstra WJ. Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 2444-7. PMID 24775307 DOI: 10.1016/j.bmcl.2014.04.024  0.046
2008 Mayer SC, Kreft AF, Harrison B, Abou-Gharbia M, Antane M, Aschmies S, Atchison K, Chlenov M, Cole DC, Comery T, Diamantidis G, Ellingboe J, Fan K, Galante R, Gonzales C, ... ... Moore W, et al. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry. 51: 7348-51. PMID 19012391 DOI: 10.1021/Jm801252W  0.043
1892 Moore W. Abstract of an Address on Famine: Delivered at the London Epidemiological Society, 16th December 1891, Surgeon-General Ewart, President. The Indian Medical Gazette. 27: 196-199. PMID 28999970  0.042
2024 Jousset Drouhin A, Tait WRT, Moore W, Yu F, Li Y, Werner JG, van Dover RB, Wiesner UB. Block copolymer self-assembly derived mesoporous magnetic materials with three-dimensionally (3D) co-continuous gyroid nanostructure. Soft Matter. PMID 38441577 DOI: 10.1039/d3sm01622f  0.042
1972 Moore WR, Bach RD. Formation of optically active 1,2-cyclononadiene from two different cyclopropylidene precursors Journal of the American Chemical Society. 94: 3148-3152. DOI: 10.1021/JA00764A043  0.042
2015 Moore WR, Norris JD, Wardell S, Eisner JR, Hoekstra WJ, Schotzinger RJ, McDonnell DP. Direct effects of the selective CYP17 lyase (L) inhibitor, VT-464, on the androgen receptor (AR) and its oral activity in an F876L tumor mouse xenograft model. Journal of Clinical Oncology. 33: 263-263. DOI: 10.1200/Jco.2015.33.7_Suppl.263  0.041
1988 Huang CS, Moore WR, Meister A. On the active site thiol of gamma-glutamylcysteine synthetase: relationships to catalysis, inhibition, and regulation. Proceedings of the National Academy of Sciences of the United States of America. 85: 2464-8. PMID 2895925 DOI: 10.1073/Pnas.85.8.2464  0.039
2017 Chaudhry AA, Gul M, Chaudhry AA, Moore W. Case 238: Spontaneous Pneumothorax Secondary to Intrapulmonary Necrobiotic Rheumatoid Nodule. Radiology. 282: 602-608. PMID 28099107 DOI: 10.1148/radiol.2016150224  0.039
2017 Gucalp A, Danso MA, Elias AD, Bardia A, Ali HY, Potter D, Gabrail NY, Haley BB, Khong HT, Riley EC, Ervin L, Eisner JR, Baskin-Bey, M.D. E, Moore WR, et al. Phase (Ph) 2 stage 1 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor, in women with advanced AR+ triple-negative breast cancer (TNBC) or estrogen receptor (ER)+ BC: CLARITY-01. Journal of Clinical Oncology. 35: 1102-1102. DOI: 10.1200/JCO.2017.35.15_SUPPL.1102  0.039
1997 Elrod KC, Moore WR, Abraham WM, Tanaka RD. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. American Journal of Respiratory and Critical Care Medicine. 156: 375-81. PMID 9279212 DOI: 10.1164/ajrccm.156.2.9607012  0.039
2012 Benveniste H, Zhang S, Reinsel RA, Li H, Lee H, Rebecchi M, Moore W, Johansen C, Rothman DL, Bilfinger TV. Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy. International Journal of Clinical and Experimental Medicine. 5: 154-64. PMID 22567176  0.038
2018 Dane B, Doshi A, Gfytopoulos S, Bhattacharji P, Recht M, Moore W. Automated Radiology-Pathology Module Correlation Using a Novel Report Matching Algorithm by Organ System. Academic Radiology. PMID 29373209 DOI: 10.1016/j.acra.2017.11.009  0.038
2012 Gardner ER, Kelly M, Springman E, Lee KJ, Li H, Moore W, Figg WD. Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab. Investigational New Drugs. 30: 90-7. PMID 20820910 DOI: 10.1007/S10637-010-9520-5  0.038
1961 Moore WR, Ward HR, Merritt RF. THE FORMATION OF HIGHLY-STRAINED SYSTEMS BY THE INTRAMOLECULAR INSERTION OF A CYCLOPROPYLIDENE: TRICYCLO[4.1.0.02,7]-HEPTANE AND TRICYCLO[4.1.0.03,7]HEPTANE3 Journal of the American Chemical Society. 83: 2019-2020. DOI: 10.1021/JA01469A061  0.038
2015 Chaudhry A, Grechushkin V, Hoshmand M, Kim CW, Pena A, Huston B, Chaya Y, Bilfinger T, Moore W. Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules. Medicine. 94: e1672. PMID 26496275 DOI: 10.1097/MD.0000000000001672  0.037
1996 Molinari JF, Scuri M, Moore WR, Clark J, Tanaka R, Abraham WM. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. American Journal of Respiratory and Critical Care Medicine. 154: 649-53. PMID 8810600 DOI: 10.1164/Ajrccm.154.3.8810600  0.037
2012 Figg WD, Spencer SD, Pisle ST, Pressler HM, Troutman SM, Eisner JR, Rafferty SW, Schotzinger RJ, Moore WR. Activity of oral VT-464, a selective CYP17-lyase inhibitor, in the LNCaP prostate cancer xenograft. Journal of Clinical Oncology. 30: 4671-4671. DOI: 10.1200/Jco.2012.30.15_Suppl.4671  0.037
2015 Han H, Li L, Han F, Song B, Moore W, Liang Z. Fast and adaptive detection of pulmonary nodules in thoracic CT images using a hierarchical vector quantization scheme. Ieee Journal of Biomedical and Health Informatics. 19: 648-59. PMID 25486657 DOI: 10.1109/JBHI.2014.2328870  0.036
2007 Moore WR, Donnelly E. Thermal degradation of melamine-formaldehyde resins Journal of Applied Chemistry. 13: 537-543. DOI: 10.1002/JCTB.5010131202  0.035
2018 Yeo DCM, Figg S, Moore W. Direct View of the Angle Structures in Bilateral Congenital Megalocornea. Ophthalmology. 125: 700. PMID 29681294 DOI: 10.1016/j.ophtha.2018.01.008  0.035
2012 Pisle ST, Pressler HM, Troutman SM, Eisner JR, Rafferty SW, Schotzinger RJ, Moore WR, Figg WD. Activity of VT-464, a selective CYP17 lyase inhibitor, in the LNCaP prostate cancer xenograft model. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 64. PMID 28142955 DOI: 10.1200/jco.2012.30.5_suppl.64  0.035
2012 Pisle ST, Pressler HM, Troutman SM, Eisner JR, Rafferty SW, Schotzinger RJ, Moore WR, Figg WD. Activity of VT-464, a selective CYP17 lyase inhibitor, in the LNCaP prostate cancer xenograft model. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 64. PMID 27967896 DOI: 10.1200/Jco.2012.30.5_Suppl.64  0.035
2016 Kurman MR, Sager P, Rudoltz MS, Eisner J, Goodman D, Heyman E, Salvail D, Bell C, Moore WR. Cardiovascular safety profile of VT-464 in patients (pts) with castrate-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 34: 198-198. DOI: 10.1200/JCO.2016.34.2_SUPPL.198  0.035
2003 Loktionov A, Moore W, Spencer SP, Vorster H, Nell T, O'Neill IK, Bingham SA, Cummings JH. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention. Cancer Detection and Prevention. 26: 15-22. PMID 12088198 DOI: 10.1016/s0361-090x(02)00010-7  0.034
2018 Jester R, Znoyko I, Garnovskaya M, Rozier JN, Kegl R, Patel S, Tran T, Abedalthagafi M, Horbinski CM, Richardson M, Wolff DJ, Lapadat R, Moore W, Rodriguez FJ, Mull J, et al. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathologica Communications. 6: 107. PMID 30340515 DOI: 10.1186/S40478-018-0607-0  0.034
2008 Kreft A, Harrison B, Aschmies S, Atchison K, Casebier D, Cole DC, Diamantidis G, Ellingboe J, Hauze D, Hu Y, Huryn D, Jin M, Kubrak D, Lu P, Lundquist J, ... ... Moore W, et al. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 4232-6. PMID 18556202 DOI: 10.1016/J.Bmcl.2008.05.064  0.034
2016 Nordquist LT, Shore ND, De Bono JS, Gupta S, Berry WR, Gillessen S, Liu G, Vogelzang NJ, Efstathiou E, Fleming MT, George DJ, Araujo JC, Zhang J, Kurman MR, Eisner JR, ... Moore WR, et al. Objective response of the dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist, VT-464, in patients with CRPC. Journal of Clinical Oncology. 34: 273-273. DOI: 10.1200/JCO.2016.34.2_SUPPL.273  0.033
2016 Kanakia S, Toussaint J, Kukarni P, Lee S, Chowdhury SM, Khan S, Mallipattu SK, Shroyer KR, Moore W, Sitharaman B. Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities. Graphene Technology. 1: 17-28. PMID 28261636 DOI: 10.1007/s41127-016-0001-2  0.032
1993 Wannamaker M, Waid PP, Moore WR, Schatzman GL, Van Sickle WA, Wilson PK. Inhibition of 2,3-oxidosqualene cyclase by N-alkylpiperidines Bioorganic & Medicinal Chemistry Letters. 3: 1175-1178. DOI: 10.1016/S0960-894X(00)80309-1  0.032
2019 Tolisano AM, Hunter JB, Sakai M, Kutz JW, Moore W, Pinho M, Isaacson B. Determining Etiology of Facial Nerve Paralysis With MRI: Challenges in Malignancy Detection. The Annals of Otology, Rhinology, and Laryngology. 3489419848462. PMID 31067979 DOI: 10.1177/0003489419848462  0.031
2014 Toren P, Pham S, Kim S, Adomat H, Zoubeidi A, Moore W, Gleave M. MP70-05 ANTI-CANCER ACTIVITY OF THE SELECTIVE CYP17A1 INHIBITOR, VT-464, IN PRE-CLINICAL MODELS OF CASTRATE RESISTANT PROSTATE CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2204  0.03
1995 Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR, Tanaka RD. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. American Journal of Respiratory and Critical Care Medicine. 152: 2076-83. PMID 8520778 DOI: 10.1164/ajrccm.152.6.8520778  0.029
2022 Chen X, Rundle MM, Kennedy KM, Moore W, Park DC. Functional activation features of memory in successful agers across the adult lifespan. Neuroimage. 119276. PMID 35523368 DOI: 10.1016/j.neuroimage.2022.119276  0.029
2020 Moore W. Famine: Its Effects and Relief. Transactions. Epidemiological Society of London. 11: 27-46. PMID 29419091  0.029
2020 Agyemang A, Farrell C, Moore W, Parkin J. A Physiologically Based Pharmacokinetic Model to Predict Potential Drug-Drug Interactions and Inform Dosing of Acumapimod, an Oral p38 MAPK Inhibitor. Cpt: Pharmacometrics & Systems Pharmacology. PMID 33107218 DOI: 10.1002/psp4.12565  0.028
2021 Shamout FE, Shen Y, Wu N, Kaku A, Park J, Makino T, Jastrzębski S, Witowski J, Wang D, Zhang B, Dogra S, Cao M, Razavian N, Kudlowitz D, Azour L, ... Moore W, et al. An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department. Npj Digital Medicine. 4: 80. PMID 33980980 DOI: 10.1038/s41746-021-00453-0  0.028
2022 Mabud TS, Zhu Y, Guichet PL, Agnihotri T, Patel B, Azour L, Taslakian B, Garay S, Moore W. Computed Tomography Evaluation of In Vivo Pulmonary Cryoablation Zone Sizes. Journal of Vascular and Interventional Radiology : Jvir. PMID 35940364 DOI: 10.1016/j.jvir.2022.07.026  0.028
2001 Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. Anz Journal of Surgery. 71: 354-61. PMID 11409021  0.027
2014 Liu Y, Liang Z, Ma J, Lu H, Wang K, Zhang H, Moore W. Total variation-stokes strategy for sparse-view X-ray CT image reconstruction. Ieee Transactions On Medical Imaging. 33: 749-63. PMID 24595347 DOI: 10.1109/TMI.2013.2295738  0.027
2019 Ko JP, Girvin F, Moore W, Naidich DP. Approach to Peribronchovascular Disease on CT. Seminars in Ultrasound, Ct, and Mr. 40: 187-199. PMID 31200868 DOI: 10.1053/j.sult.2018.12.002  0.027
2016 Shore ND, Nordquist LT, Gupta S, Fleming MT, Berry WR, Zhang J, Kurman MR, Eisner JR, Moore WR. Once-nightly (QD) dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist VT-464 in patients with CRPC. Journal of Clinical Oncology. 34: 343-343. DOI: 10.1200/JCO.2016.34.2_SUPPL.343  0.027
2023 Mabud TS, Swilling D, Guichet P, Zhu Y, Manduca S, Patel B, Azour L, Taslakian B, Garay SM, Moore W. Pulmonary Cryoablation Outcomes in Octo- and Nonagenarians with Primary Lung Cancer. Journal of Vascular and Interventional Radiology : Jvir. PMID 37527771 DOI: 10.1016/j.jvir.2023.07.022  0.026
1991 Davies RP, Downey PR, Moore WR, Jeans PL, Toouli J. Contrast cholangiography versus ultrasonographic measurement of the "extrahepatic" bile duct: a two-fold discrepancy revisited. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 10: 653-7. PMID 1766032  0.026
2008 Dunn T, Blankenship D, Beal N, Allen R, Schechter E, Moore W, Perveen G, Eichner J. HFE mutations in heart disease. Heart and Vessels. 23: 348-55. PMID 18810584 DOI: 10.1007/S00380-008-1047-8  0.026
2012 Usman M, Moore W, Talati R, Watkins K, Bilfinger TV. Irreversible electroporation of lung neoplasm: a case series. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 18: CS43-7. PMID 22648257  0.026
2002 Prokop A, Kozlov E, Moore W, Davidson JM. Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. Journal of Pharmaceutical Sciences. 91: 67-76. PMID 11782898 DOI: 10.1002/Jps.1171  0.026
2023 Moore J, Basurto-Lozada D, Besson S, Bogovic J, Brown EM, Burel JM, de Medeiros G, Diel EE, Gault D, Ghosh SS, Gold I, Halchenko YO, Hartley M, Horsfall D, Keller MS, ... ... Moore W, et al. OME-Zarr: a cloud-optimized bioimaging file format with international community support. Biorxiv : the Preprint Server For Biology. PMID 36865282 DOI: 10.1101/2023.02.17.528834  0.026
1995 Molinari JF, Moore WR, Clark J, Tanaka R, Butterfield JH, Abraham WM. Role of tryptase in immediate cutaneous responses in allergic sheep. Journal of Applied Physiology (Bethesda, Md. : 1985). 79: 1966-70. PMID 8847261  0.026
2015 Kanakia S, Toussaint J, Hoang DM, Mullick Chowdhury S, Lee S, Shroyer KR, Moore W, Wadghiri YZ, Sitharaman B. Towards An Advanced Graphene-Based Magnetic Resonance Imaging Contrast Agent: Sub-acute Toxicity and Efficacy Studies in Small Animals. Scientific Reports. 5: 17182. PMID 26625867 DOI: 10.1038/Srep17182  0.025
2020 Han F, Yan L, Chen J, Teng Y, Chen S, Qi S, Qian W, Yang J, Moore W, Zhang S, Liang Z. Predicting Unnecessary Nodule Biopsies from a Small, Unbalanced, and Pathologically Proven Dataset by Transfer Learning. Journal of Digital Imaging. PMID 32144499 DOI: 10.1007/s10278-019-00306-z  0.025
2005 Fredericson M, Moore W, Guillet M, Beaulieu C. High hamstring tendinopathy in runners: meeting the challenges of diagnosis, treatment, and rehabilitation. The Physician and Sportsmedicine. 33: 32-43. PMID 20086362 DOI: 10.3810/psm.2005.05.89  0.025
2020 Moore W. Is the Colonisation of Tropical Africa by Europeans Possible? Transactions. Epidemiological Society of London. 10: 27-45. PMID 29419095  0.025
2021 Sriram A, Muckley M, Sinha K, Shamout F, Pineau J, Geras KJ, Azour L, Aphinyanaphongs Y, Yakubova N, Moore W. COVID-19 Deterioration Prediction via Self-Supervised Representation Learning and Multi-Image Prediction. Arxiv. PMID 33469559  0.025
2023 Moore J, Basurto-Lozada D, Besson S, Bogovic J, Bragantini J, Brown EM, Burel JM, Casas Moreno X, de Medeiros G, Diel EE, Gault D, Ghosh SS, Gold I, Halchenko YO, Hartley M, ... ... Moore W, et al. OME-Zarr: a cloud-optimized bioimaging file format with international community support. Histochemistry and Cell Biology. PMID 37428210 DOI: 10.1007/s00418-023-02209-1  0.024
2020 Shamout FE, Shen Y, Wu N, Kaku A, Park J, Makino T, Jastrzębski S, Wang D, Zhang B, Dogra S, Cao M, Razavian N, Kudlowitz D, Azour L, Moore W, et al. An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department. Arxiv. PMID 32793769  0.024
2017 Bhattacharji P, Moore W. Application of Real-Time 3D Navigation System in CT-Guided Percutaneous Interventional Procedures: A Feasibility Study. Radiology Research and Practice. 2017: 3151694. PMID 29181197 DOI: 10.1155/2017/3151694  0.024
2014 Zhang H, Han H, Wang J, Ma J, Liu Y, Moore W, Liang Z. Deriving adaptive MRF coefficients from previous normal-dose CT scan for low-dose image reconstruction via penalized weighted least-squares minimization. Medical Physics. 41: 041916. PMID 24694147 DOI: 10.1118/1.4869160  0.024
2019 Patel SM, Dackiw APB, Moore W, Abramowitz J. Utilization of Unconventional Radiography to Localize an Insulinoma. The American Journal of Medicine. PMID 31585065 DOI: 10.1016/j.amjmed.2019.08.044  0.023
2003 Moore W, Zhang C, Clarke PR. Targeting of RCC1 to chromosomes is required for proper mitotic spindle assembly in human cells. Current Biology : Cb. 12: 1442-7. PMID 12194828 DOI: 10.1016/s0960-9822(02)01076-x  0.023
2020 Tsay JJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, Yie TA, Meyn P, Olsen E, Perez L, Franca B, Carpenito J, Iizumi T, El-Ashmawy M, Badri M, ... ... Moore W, et al. Lower airway dysbiosis affects lung cancer progression. Cancer Discovery. PMID 33177060 DOI: 10.1158/2159-8290.CD-20-0263  0.023
2020 Bhattacharji P, Moore W, Yaddanapudi K. Keratin 17 is an imaging biomarker in lung cancers. Journal of Thoracic Disease. 12: 5062-5066. PMID 33145082 DOI: 10.21037/jtd.2019.08.33  0.022
2004 Moore W, Preece JW. Radiography and low birth weight. Journal of the American Dental Association (1939). 135: 858, 860, 862. PMID 15354896 DOI: 10.14219/jada.archive.2004.0322  0.022
2019 Sullivan JT, Berkoff T, Gronoff G, Knepp T, Pippin M, Allen D, Twigg L, Swap R, Tzortziou M, Thompson AM, Stauffer RM, Wolfe GM, Flynn J, Pusede SE, Judd L, ... Moore W, et al. The Ozone Water-Land Environmental Transition Study (OWLETS): An Innovative Strategy for Understanding Chesapeake Bay Pollution Events. Bulletin of the American Meteorological Society. 100: 291-306. PMID 33005058 DOI: 10.1175/Bams-D-18-0025.1  0.022
2022 Troia G, Stamps DS, Lotspeich RR, Duda J, McCoy KJ, Moore W, Hensel P, Hippenstiel R, McKenna T, Andreasen D, Geoghegan C, Ulizio TP, Kronebusch M, Carr J, Walters D, et al. GPS data from 2019 and 2020 campaigns in the Chesapeake Bay region towards quantifying vertical land motions. Scientific Data. 9: 744. PMID 36460674 DOI: 10.1038/s41597-022-01864-8  0.022
1996 Clark J, Moore W, Tanaka R. Trytase inhibitors: a new class of antiinflammatory drugs Drugs of the Future. 21: 811. DOI: 10.1358/DOF.1996.021.08.375541  0.022
2019 Doshi AM, Huang C, Melamud K, Shanbhogue K, Slywotsky C, Taffel M, Moore W, Recht M, Kim D. Utility of an Automated Radiology-Pathology Feedback Tool. Journal of the American College of Radiology : Jacr. PMID 31072775 DOI: 10.1016/j.jacr.2019.03.001  0.022
1972 Moore WR, Smith PL. Swaged gold eyelid weights. The Dental Technician. 25: 151-2. PMID 4506426  0.021
2017 Zhang H, Ma J, Wang J, Moore W, Liang Z. Assessment of prior image induced nonlocal means regularization for low-dose CT reconstruction: Change in anatomy. Medical Physics. 44: e264-e278. PMID 28901622 DOI: 10.1002/mp.12378  0.021
2020 Madan RA, Schmidt KT, Karzai F, Peer CJ, Cordes LM, Chau CH, Steinberg SM, Owens H, Eisner J, Moore WR, Dahut WL, Gulley JL, Figg WD. Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment. Clinical Genitourinary Cancer. PMID 32327394 DOI: 10.1016/J.Clgc.2019.11.002  0.021
2006 Moore W, Baram D, Hu Y. Pulmonary infiltration from chronic lymphocytic leukemia. Journal of Thoracic Imaging. 21: 172-5. PMID 16770234 DOI: 10.1097/00005382-200605000-00009  0.021
2017 Moore W, Doshi A, Bhattacharji P, Gyftopoulos S, Ciavarra G, Kim D, Recht M. Automated Radiology-Operative Note Communication Tool; Closing the Loop in Musculoskeletal Imaging. Academic Radiology. PMID 29122473 DOI: 10.1016/j.acra.2017.08.016  0.021
2020 Moore W. Nightmare. The Hospital. 6: 324. PMID 29816522  0.021
2020 Moore W, Ko J, Gozansky E. Artificial Intelligence Pertaining to Cardiothoracic Imaging and Patient Care: Beyond Image Interpretation. Journal of Thoracic Imaging. PMID 32141963 DOI: 10.1097/RTI.0000000000000486  0.021
2019 Chen X, Farrell ME, Moore W, Park DC. Actual memory as a mediator of the amyloid-subjective cognitive decline relationship. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 151-160. PMID 30809586 DOI: 10.1016/J.Dadm.2018.12.007  0.021
2001 Krahn LE, Moore WR, Altchuler SI. Narcolepsy and obesity: remission of severe cataplexy with sibutramine. Sleep Medicine. 2: 63-65. PMID 11152984  0.021
2019 Voigt B, Moore W, Manno M, Walter J, Jeremiason JD, Aydil ES, Leighton C. Transport Evidence for Sulfur Vacancies as the Origin of Unintentional n-Type Doping in Pyrite FeS. Acs Applied Materials & Interfaces. PMID 31008575 DOI: 10.1021/Acsami.9B01335  0.02
2024 Azour L, Chandarana H, Maier C, Babb J, Moore W. Low Field MRI Surveillance 6-24 Months Post-acute COVID-19 Pneumonia: Factors Influencing Severity and Evolution of Lung Opacities. Academic Radiology. PMID 38443207 DOI: 10.1016/j.acra.2024.02.021  0.02
2015 Moore W, Bonvento MJ, Lee D, Dunkin J, Bhattacharji P. Reduction of fetal dose in computed tomography using anterior shields. Journal of Computer Assisted Tomography. 39: 298-300. PMID 25786095 DOI: 10.1097/RCT.0000000000000190  0.02
2018 Singh J, Moore W, Fattah F, Jiang X, Zheng J, Kurian P, Beg MS, Khan SA. Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer. Head & Neck. PMID 30537286 DOI: 10.1002/hed.25492  0.02
2018 Ishikawa T, Fang L, Rennie EA, Sechet J, Yan J, Jing B, Moore W, Cahoon EB, Scheller HV, Kawai-Yamada M, Mortimer JC. GLUCOSAMINE INOSITOLPHOSPHORYLCERAMIDE TRANSFERASE1 (GINT1) is a GlcNAc-containing glycosylinositol phosphorylceramide glycosyltransferase. Plant Physiology. PMID 29760197 DOI: 10.1104/Pp.18.00396  0.02
2013 Moore W, Freiberg E, Bishawi M, Halbreiner MS, Matthews R, Baram D, Bilfinger TV. FDG-PET imaging in patients with pulmonary carcinoid tumor. Clinical Nuclear Medicine. 38: 501-5. PMID 23486331 DOI: 10.1097/RLU.0b013e318279f0f5  0.019
2020 Gao Y, Liang Z, Zhang H, Yang J, Ferretti J, Bilfinger T, Yaddanapudi K, Schweitzer M, Bhattacharji P, Moore W. A Task-dependent Investigation on Dose and Texture in CT Image Reconstruction. Ieee Transactions On Radiation and Plasma Medical Sciences. 4: 441-449. PMID 33907724 DOI: 10.1109/trpms.2019.2957459  0.019
2016 Bardia A, Dacosta NA, Gabrail NY, Lemon S, Danso MA, Ali HY, Fleming RA, Kurman MR, Eisner JR, Moore WR, Gucalp A, Traina TA. Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR+ triple negative (TNBC) or estrogen receptor (ER)+ breast cancer (BC). Journal of Clinical Oncology. 34: 1088-1088. DOI: 10.1200/JCO.2016.34.15_SUPPL.1088  0.019
2007 Fredericson M, Moore W, Biswal S. Sacral stress fractures: magnetic resonance imaging not always definitive for early stage injuries: a report of 2 cases. The American Journal of Sports Medicine. 35: 835-9. PMID 17261568 DOI: 10.1177/0363546506296519  0.018
2020 Kaminetzky M, Moore W, Fansiwala K, Babb JS, Kaminetzky D, Horwitz LI, McGuinness G, Knoll A, Ko JP. Pulmonary Embolism at CT Pulmonary Angiography in Patients with COVID-19. Radiology. Cardiothoracic Imaging. 2: e200308. PMID 33778610 DOI: 10.1148/ryct.2020200308  0.018
2013 Chowdhury SM, Kanakia S, Toussaint JD, Frame MD, Dewar AM, Shroyer KR, Moore W, Sitharaman B. In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene. Scientific Reports. 3: 2584. PMID 24002570 DOI: 10.1038/Srep02584  0.018
2021 Coster SS, Dillon MN, Moore W, Merovich GT. The update and optimization of an eDNA assay to detect the invasive rusty crayfish (Faxonius rusticus). Plos One. 16: e0259084. PMID 34714850 DOI: 10.1371/journal.pone.0259084  0.018
2023 Voigt B, Valor LS, Moore W, Jeremiason J, Kakalios J, Aydil ES, Leighton C. Controlled -Type Doping of Pyrite FeS. Acs Applied Materials & Interfaces. PMID 37265426 DOI: 10.1021/acsami.3c04662  0.018
2006 Moore W, Franceschi D. PET findings in pulmonary dirofilariasis. Journal of Thoracic Imaging. 20: 305-6. PMID 16282912 DOI: 10.1097/01.rti.0000181524.95015.ea  0.018
2022 Salahuddin H, Saherwala A, Pinho MC, Moore W, Castonguay A, Khan NI, Jeelani F, Uppal H, He H, Campbell J, Shang T. Association of distal hyperintense vessel sign and recurrent stroke in patients with symptomatic intracranial stenosis. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 31: 106616. PMID 35816788 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106616  0.018
2015 Moore W, Chaya Y, Chaudhry A, Depasquale B, Glass S, Lee S, Shin J, Mikhail G, Bhattacharji P, Kim B, Bilfinger T. Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy. Journal of Computer Assisted Tomography. 39: 804-9. PMID 25974720 DOI: 10.1097/RCT.0000000000000262  0.017
1992 Moore WR. The purification and properties of cancer procoagulant from murine tumors. Biochemical and Biophysical Research Communications. 184: 819-24. PMID 1575750  0.017
2015 Yoon JH, Grechushkin V, Chaudhry A, Bhattacharji P, Durkin B, Moore W. Cryoneurolysis in Patients with Refractory Chronic Peripheral Neuropathic Pain. Journal of Vascular and Interventional Radiology : Jvir. PMID 26710969 DOI: 10.1016/j.jvir.2015.11.027  0.017
1986 Moore WR. Caustic ingestions. Pathophysiology, diagnosis, and treatment. Clinical Pediatrics. 25: 192-6. PMID 3512143  0.017
2019 Kang SK, Doshi AM, Recht MP, Lover AC, Kim DC, Moore W. Process Improvement for Communication and Follow-up of Incidental Lung Nodules. Journal of the American College of Radiology : Jacr. PMID 31899183 DOI: 10.1016/j.jacr.2019.11.023  0.017
2021 Moore WR, Sharp M, Bell C, Freeman S, Parr A, Eisner JR, Schotzinger R. Abiraterone decanoate (AD): Potent and long-acting activity of a novel intramuscular (IM) abiraterone prodrug depot in a castrate monkey model. Journal of Clinical Oncology. 39: 78-78. DOI: 10.1200/JCO.2021.39.6_SUPPL.78  0.016
1995 Tanaka RD, Clark JM, Warne RL, Abraham WM, Moore WR. Mast cell tryptase: a new target for therapeutic intervention in asthma. International Archives of Allergy and Immunology. 107: 408-9. PMID 7613193  0.016
2021 Prodinger C, Chottianchaiwat S, Mellerio JE, McGrath JA, Ozoemena L, Liu L, Moore W, Laimer M, Petrof G, Martinez AE. The natural history of laryngo-onycho-cutaneous syndrome: A case series of six pediatric patients and literature review. Pediatric Dermatology. PMID 34514630 DOI: 10.1111/pde.14790  0.016
2015 LoGiurato B, Matthews R, Safaie E, Moore W, Bilfinger T, Relan N, Franceschi D. 18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer. Nuclear Medicine Communications. 36: 908-13. PMID 25973693 DOI: 10.1097/MNM.0000000000000344  0.016
2003 Moore W, Li S, Rifkin MD. Juvenile granulosal cell tumor of the testicle. Ultrasound Quarterly. 19: 39-41. PMID 12970615 DOI: 10.1097/00013644-200303000-00005  0.016
2023 York B, Walsh D, Moore W, Yaguda S, Parala-Metz A, Raj VS, Szafranski M, Waldman J. Supportive oncology in a cancer center: development of a novel department (2017-2021). Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 31: 692. PMID 37955710 DOI: 10.1007/s00520-023-08110-w  0.015
2012 Leng T, Marmor MF, Kellner U, Thompson DA, Renner AB, Moore W, Sowden JC. Foveal cavitation as an optical coherence tomography finding in central cone dysfunction. Retina (Philadelphia, Pa.). 32: 1411-9. PMID 22466470 DOI: 10.1097/IAE.0b013e318236e4ea  0.015
2016 Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. Journal of Vascular and Interventional Radiology : Jvir. 26: 312-9. PMID 25735518 DOI: 10.1016/j.jvir.2014.12.006  0.015
2015 Alkhalidy H, Moore W, Zhang Y, McMillan R, Wang A, Ali M, Suh KS, Zhen W, Cheng Z, Jia Z, Hulver M, Liu D. Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β -Cell Mass in Middle-Aged Obese Diabetic Mice. Journal of Diabetes Research. 2015: 532984. PMID 26064984 DOI: 10.1155/2015/532984  0.015
2019 You H, Xi Y, Moore W, Sher D, Sanli Y, Subramaniam RM. Timing and Impact of Posttreatment PET/CT After First 6 Months on Patient Management and Outcomes in Oropharyngeal Squamous Cell Carcinoma. Ajr. American Journal of Roentgenology. 1-6. PMID 30835513 DOI: 10.2214/AJR.18.20619  0.014
2006 Moore W, Fields J, Mieczkowski B. Multidetector computed tomography pulmonary angiogram in the assessment of myocardial infarction. Journal of Computer Assisted Tomography. 30: 800-3. PMID 16954933 DOI: 10.1097/01.rct.0000230001.15650.05  0.014
2021 Chen X, Farrell ME, Rundle MM, Chan MY, Moore W, Wig GS, Park DC. The relationship of functional hippocampal activity, amyloid deposition, and longitudinal memory decline to memory complaints in cognitively healthy older adults. Neurobiology of Aging. 105: 318-326. PMID 34147860 DOI: 10.1016/j.neurobiolaging.2021.04.020  0.014
2010 Moore W, Kolnick D, Tan J, Yu HS. CT guided percutaneous cryoneurolysis for post thoracotomy pain syndrome: early experience and effectiveness. Academic Radiology. 17: 603-6. PMID 20227306 DOI: 10.1016/j.acra.2010.01.009  0.014
2023 Jones TH, Dobs AS, Randeva H, Moore W, Parkin JM. Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial. European Journal of Endocrinology. 189: 297-308. PMID 37579053 DOI: 10.1093/ejendo/lvad099  0.014
2015 Zhang H, Han H, Liang J, Hu Y, Liu Y, Moore W, Ma J, Lu H. Extracting information from previous full-dose CT scan for knowledge-based Bayesian reconstruction of current low-dose CT images. Ieee Transactions On Medical Imaging. PMID 26561284 DOI: 10.1109/TMI.2015.2498148  0.014
2022 Ernst J, Medsinge A, Scanga HL, Hiasat J, Moore W, Ali A, Levin AV, Stahl ED, Nischal KK. Congenital primary aphakia. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus. PMID 35051625 DOI: 10.1016/j.jaapos.2021.09.008  0.014
2018 Sarkar H, Moore W, Leroy BP, Moosajee M. CUGC for congenital primary aphakia. European Journal of Human Genetics : Ejhg. PMID 29769628 DOI: 10.1038/s41431-018-0171-x  0.014
2019 Moore W, Doshi A, Gyftopoulos S, Bhattacharji P, Rosenkrantz AB, Kang SK, Recht M. Enhancing communication in radiology using a hybrid computer-human based system. Clinical Imaging. 61: 95-98. PMID 32004954 DOI: 10.1016/j.clinimag.2019.09.017  0.014
2024 Bhattacharji P, Moore W, Yaddanapudi K. Retraction to keratin 17 is an imaging biomarker in lung cancers. Journal of Thoracic Disease. 16: 825. PMID 38410589 DOI: 10.21037/jtd-2023-18  0.014
2021 Burningham K, Moore W, Moon D, Avkshtol V, Day AT, Sumer B, Vo D, Bishop JA, Hughes R, Sher DJ. Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy. Oral Oncology. 123: 105623. PMID 34801975 DOI: 10.1016/j.oraloncology.2021.105623  0.014
2013 Bishawi M, Moore W, Bilfinger T. Severity of emphysema predicts location of lung cancer and 5-y survival of patients with stage I non-small cell lung cancer. The Journal of Surgical Research. 184: 1-5. PMID 23810745 DOI: 10.1016/j.jss.2013.05.081  0.013
2015 Garvey EP, Hoekstra WJ, Moore WR, Schotzinger RJ, Long L, Ghannoum MA. VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model. Antimicrobial Agents and Chemotherapy. 59: 1992-7. PMID 25605358 DOI: 10.1128/AAC.04902-14  0.013
2020 Moore W. Can Tropical Africa Be Colonised? The Hospital. 8: 206-207. PMID 29826903  0.013
2016 Wang A, Luo J, Moore W, Alkhalidy H, Wu L, Zhang J, Zhen W, Wang Y, Clegg DJ, Bin Xu, Cheng Z, McMillan RP, Hulver MW, Liu D. GPR30 regulates diet-induced adiposity in female mice and adipogenesis in vitro. Scientific Reports. 6: 34302. PMID 27698362 DOI: 10.1038/Srep34302  0.012
1968 Moore WR, Scannell JG. Pulmonary actinomycosis simulating cancer of the lung. The Journal of Thoracic and Cardiovascular Surgery. 55: 193-5. PMID 5635978  0.012
2020 Moore W. Opium and Its Votaries. The Hospital. 6: 5-6. PMID 29816466  0.012
2020 Moore W. Malaria More Recognisable Causes of Disease. Transactions. Epidemiological Society of London. 9: 23-46. PMID 29419108  0.012
2008 Crosbie A, Eichner J, Moore W. Body mass index screening and volunteer bias. Annals of Epidemiology. 18: 602-4. PMID 18652977 DOI: 10.1016/j.annepidem.2008.04.008  0.012
2003 Olson EJ, Moore WR, Morgenthaler TI, Gay PC, Staats BA. Obstructive sleep apnea-hypopnea syndrome. Mayo Clinic Proceedings. 78: 1545-52. PMID 14661684 DOI: 10.4065/78.12.1545  0.012
2020 Sher DJ, Pham NL, Shah JL, Sen N, Williams KA, Subramaniam RM, Moore W, Chorley R, Ahn C, Khan SM. Prospective phase II study of radiotherapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33127491 DOI: 10.1016/j.ijrobp.2020.09.063  0.011
1957 MOORE WR. Inguinal endometriosis in bilateral hernia sacs associated with extensive pelvic endometriosis. Harper Hospital Bulletin. 15: 242-5. PMID 13562731  0.011
1996 Sutter RP, Grandin AB, Dye BD, Moore WR. (-) mating type-specific mutants of Phycomyces defective in sex pheromone biosynthesis. Fungal Genetics and Biology : Fg & B. 20: 268-79. PMID 9045757 DOI: 10.1006/fgbi.1996.0041  0.011
2015 Zhang H, Ma J, Wang J, Liu Y, Han H, Lu H, Moore W, Liang Z. Statistical image reconstruction for low-dose CT using nonlocal means-based regularization. Part II: An adaptive approach. Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society. 43: 26-35. PMID 25795593 DOI: 10.1016/j.compmedimag.2015.02.008  0.01
2020 Moore W. Being an African American Male in Birth Work. Creative Nursing. 26: 114-117. PMID 32321795 DOI: 10.1891/CRNR-D-20-00013  0.01
2014 Kanakia S, Toussaint JD, Mullick Chowdhury S, Tembulkar T, Lee S, Jiang YP, Lin RZ, Shroyer KR, Moore W, Sitharaman B. Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials. 35: 7022-31. PMID 24854092 DOI: 10.1016/J.Biomaterials.2014.04.066  0.01
2023 Smits A, Ten Eikelder M, Dhanis J, Moore W, Blake D, Zusterzeel P, Kucukmetin A, Ratnavelu N, Rundle S. Finding the sentinel lymph node in early cervical cancer: When is unusual not uncommon? Gynecologic Oncology. 170: 84-92. PMID 36657244 DOI: 10.1016/j.ygyno.2022.12.013  0.01
2021 Ko JP, Goldstein JM, Latson LA, Azour L, Gozansky EK, Moore W, Patel S, Hutchinson B. Chest CT Angiography for Acute Aortic Pathologic Conditions: Pearls and Pitfalls. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 41: 399-424. PMID 33646903 DOI: 10.1148/rg.2021200055  0.01
2020 Tsai YT, Moore W, Kim H, Budin I. Bringing rafts to life: Lessons learned from lipid organization across diverse biological membranes. Chemistry and Physics of Lipids. 104984. PMID 33203526 DOI: 10.1016/j.chemphyslip.2020.104984  0.01
2020 Gao Y, Liang Z, Xing Y, Zhang H, Pomeroy M, Lu S, Ma J, Lu H, Moore W. Characterization of Tissue-specific Pre-log Bayesian CT Reconstruction by Texture-Dose Relationship. Medical Physics. PMID 32786070 DOI: 10.1002/Mp.14449  0.01
2020 Rhodes NJ, Dairem A, Moore W, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivek ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, et al. Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 32577687 DOI: 10.1101/2020.06.03.20121558  0.01
2020 Moore W. The King of Causes of Disease. The Hospital. 4: 376-377. PMID 29836555  0.01
2020 Moore W. Doctors and Patients. The Hospital. 4: 331. PMID 29836543  0.01
2020 Moore W. The Immediate Treatment of Accidents and Sudden Illness. The Hospital. 4: 354-355. PMID 29836509  0.01
2020 Moore W. Summer Diarrhœa and Cholera. The Hospital. 6: 221. PMID 29816563  0.01
2020 Moore W. Insomnia. The Hospital. 5: 350. PMID 29814154  0.01
2020 Moore W. The Indian National Association for Supplying Female Medical Aid to the Women of India, and the Countess Dufferin's Fund. The Hospital. 5: 147-148. PMID 29814030  0.01
2020 Moore W. Socialists and Hospitals. The Hospital. 5: 125-126. PMID 29813958  0.01
2019 Bleiberg BA, Abu-Hijleh M, Moore W, Khan SA. Confluent tracheal recurrences of head and neck squamous cell carcinoma. Clinical Case Reports. 7: 1849-1853. PMID 31624596 DOI: 10.1002/ccr3.2371  0.01
2018 Patel AR, Nedzi L, Lau S, Barnett SL, Mickey BE, Moore W, Bindal S, Wardak Z, Dan T, Timmerman R, Patel TR. Neoadjuvant Stereotactic Radiosurgery Prior to Surgical Resection of Cerebral Metastases. World Neurosurgery. PMID 30149167 DOI: 10.1016/J.Wneu.2018.08.107  0.01
2017 Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer. Ajr. American Journal of Roentgenology. 209: 289-303. PMID 28731808 DOI: 10.2214/AJR.17.18301  0.01
2016 Chaudhry AA, Gul M, Chaudhry AA, Moore W. Case 238. Radiology. 281: 311-313. PMID 27643770 DOI: 10.1148/radiol.2016150223  0.01
2016 Zhang H, Han H, Liang Z, Hu Y, Liu Y, Moore W, Ma J, Lu H. Erratum to "Extracting Information From Previous Full-Dose CT Scan for Knowledge-Based Bayesian Reconstruction of Current Low-Dose CT Images". Ieee Transactions On Medical Imaging. 35: 1587. PMID 27254852 DOI: 10.1109/TMI.2016.2571878  0.01
2015 Steffen MW, Hazelton AC, Moore WR, Jenkins SM, Clark MM, Hagen PT. Improving sleep: outcomes from a worksite healthy sleep program. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1-5. PMID 25563534 DOI: 10.1097/JOM.0000000000000370  0.01
2015 De Bono JS, Pezaro CJ, Gillessen S, Shore ND, Nordquist LT, Efstathiou E, Araujo JC, Berry WR, Liu G, Vogelzang NJ, Omlin AG, Schotzinger RJ, Eisner JR, Moore WR. The oral CYP17-Lyase (L) inhibitor VT-464 in patients with CRPC. Journal of Clinical Oncology. 33: 187-187. DOI: 10.1200/JCO.2015.33.7_SUPPL.187  0.01
2013 Dane B, Grechushkin V, Plank A, Moore W, Bilfinger T. PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer. American Journal of Nuclear Medicine and Molecular Imaging. 3: 408-16. PMID 24116349  0.01
2010 Kingma DW, Allen RA, Moore W, Caughron SK, Melby M, Gillies EM, Marlar RA, Dunn ST. HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Anticancer Research. 30: 5099-104. PMID 21187496  0.01
2010 Fleige LE, Moore WR, Garlick PJ, Murphy SP, Turner EH, Dunn ML, van Lengerich B, Orthoefer FT, Schaefer SE. Recommendations for optimization of fortified and blended food aid products from the United States. Nutrition Reviews. 68: 290-315. PMID 20500790 DOI: 10.1111/J.1753-4887.2010.00288.X  0.01
2010 Moore WR, DeVries J, MacDonald J, Hare L, Carson J, Chaudhari P, DeVries J, Fontana J, Golz P, King J, MacDonald J, McCullough C, Noggle S, Rasgorshek E, Schorn S, et al. Assessing analytical variability of measurement of vitamin A in corn-soy blend. Journal of Aoac International. 93: 638-49. PMID 20480912  0.01
2007 Moore W, Krabak BJ. Chronic lateral knee pain in a cyclist: popliteal artery entrapment. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine. 17: 401-3. PMID 17873555 DOI: 10.1097/JSM.0b013e31814c3ed6  0.01
2007 Moore WR, Silber MH, Decker PA, Heim-Penokie PC, Sikkink VK, Slocumb N, Richardson JW, Krahn LE. Cataplexy Emotional Trigger Questionnaire (CETQ)--a brief patient screen to identify cataplexy in patients with narcolepsy. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 3: 37-40. PMID 17557451  0.01
2006 Weinrauch PC, Moore WR, Shooter DR, Wilkinson MP, Bonrath EM, Dedy NJ, McMeniman TJ, Jabur MK, Whitehouse SL, Crawford RW. Early prosthetic complications after unipolar hemiarthroplasty. Anz Journal of Surgery. 76: 432-5. PMID 16768762 DOI: 10.1111/j.1445-2197.2006.03757.x  0.01
2005 Lew HL, Poole JH, Alvarez S, Moore W. Soldiers with occult traumatic brain injury American Journal of Physical Medicine and Rehabilitation. 84: 393-398. PMID 15905652 DOI: 10.1097/01.phm.0000163703.91647.a7  0.01
2005 Moore WR. Maximizing discovery efficiency with a computationally driven fragment approach. Current Opinion in Drug Discovery & Development. 8: 355-64. PMID 15892251  0.01
2005 Krahn LE, Lymp JF, Moore WR, Slocumb N, Silber MH. Characterizing the emotions that trigger cataplexy. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 45-50. PMID 15746482 DOI: 10.1176/JNP.17.1.45  0.01
1992 Moore WR, Schatzman GL. Purification of 2,3-oxidosqualene cyclase from rat liver. The Journal of Biological Chemistry. 267: 22003-6. PMID 1429550  0.01
1987 Moore W, Wiener HL, Meister A. Inactivation of gamma-glutamylcysteine synthetase, but not of glutamine synthetase, by S-sulfocysteine and S-sulfohomocysteine. Journal of Biological Chemistry. 262: 16771-16777. DOI: 10.1016/s0021-9258(18)45450-6  0.01
1983 Moore WR. Perceptions of terminal illness by family physicians and relatives. Omega. 14: 369-76. PMID 11658465  0.01
1978 Moore WR, Canton HH, Raines DR. Peritoneal lavage in the treatment of acute pancreatic ascites. The American Journal of Gastroenterology. 69: 88-91. PMID 645693  0.01
1977 Moran AD, Moore WR. Energy conservation program saves $89,000 dollars. Hospital Progress. 58: 50, 52, 56-7. PMID 852845  0.01
1973 Moore WR. Care of the dying. British Medical Journal. 1: 353-4. PMID 4685634  0.01
1971 Moore WR. A first glance at terminal care. The Journal of the Royal College of General Practitioners. 21: 387-92. PMID 5559651  0.01
1965 MOORE WR. A WORD ON SYMPATHY. The Journal of the College of General Practitioners. 9: 103-5. PMID 14254262  0.01
1960 Moore WR, Ward HR. GAS-SOLID CHROMATOGRAPHY OF H2, HD, AND D2. ISOTOPIC SEPARATION AND HEATS OF ADSORPTION ON ALUMINA1 The Journal of Physical Chemistry. 64: 832-832. DOI: 10.1021/J100835A509  0.01
1958 Moore WR, Ward HR. THE SEPARATION OF ORTHOHYDROGEN AND PARAHYDROGEN Journal of the American Chemical Society. 80: 2909-2910. DOI: 10.1021/JA01544A086  0.01
1957 MOORE WR. Words of medicine. Medical World. 87: 549-50. PMID 13492850  0.01
1951 MOORE WR, WILLSON DD. Theca cell tumor of the ovary; case report. Harper Hospital Bulletin. 9: 7-10. PMID 14813601  0.01
1950 MOORE WR, COHEN ES. The obstetrical service at Harper Hospital during 1948 and 1949. Harper Hospital Bulletin. 8: 70-7. PMID 15414995  0.01
1950 COHEN ES, MOORE WR, SMITH BP. Beta-glucuronidase levels in placentas of normal and toxemic pregnancies. Harper Hospital Bulletin. 8: 152-8. PMID 14802925  0.01
1950 MAGUIRE CH, MOORE WR. Meconium peritonitis. Surgery. 28: 568-73. PMID 14776665  0.01
1950 MOORE WR, COHEN ES, McDONALD M. Serum beta-glucuronidase levels in normal and toxemic pregnancies. Harper Hospital Bulletin. 8: 141-4. PMID 14773901  0.01
1891 Moore W. On Recruiting the Anglo-Indian Army. The Indian Medical Gazette. 26: 103-104. PMID 29000605  0.01
1890 Moore W. Malaria v. More Recognisable Causes of Disease. The Indian Medical Gazette. 25: 1-2. PMID 29000564  0.01
1890 Moore W. Cause of Leprosy. The Indian Medical Gazette. 25: 225-227. PMID 29000495  0.01
Hide low-probability matches.